A cerebral arteriovenous malformation (AVM) is a vascular malformation of the brain in which arteries and veins communicate directly, without an intervening capillary bed. The abnormal vascular network at the center of the malformation is termed the nidus (Latin for “nest”). Because normal capillary resistance is absent, high-pressure arterial blood is shunted directly into the venous circulation, exposing the draining veins to abnormally elevated hemodynamic stress.
This persistent hemodynamic stress increases the risk of vessel rupture and intracranial hemorrhage, the most serious complication of a cerebral AVM.
The Spetzler–Martin grading system (grades I–V) is widely used to estimate the operative risk of cerebral AVMs and to support multidisciplinary treatment planning.
Intracerebral hemorrhage or subarachnoid hemorrhage is the most common and clinically most serious initial presentation of a cerebral AVM. Typical manifestations include sudden-onset severe headache, impaired consciousness or loss of consciousness, and focal neurological deficits such as paresis, aphasia, or visual field deficits. Each hemorrhagic event carries a clinically relevant risk of death and permanent neurological disability.
Focal or generalized seizures may result from cortical irritation caused by the AVM and surrounding gliosis, as well as hemosiderin deposition following previous microhemorrhage. In some patients, a seizure is the only clinical manifestation of an AVM.
Neurological deficits may develop as a result of altered regional cerebral hemodynamics, including a vascular steal phenomenon in which blood is preferentially shunted through the low-resistance AVM, potentially compromising perfusion of adjacent brain tissue.
Nonspecific headache may occur in the absence of acute hemorrhage. In such cases, the AVM is often detected incidentally during subsequent neuroimaging.
Pulsatile tinnitus is uncommon but may occur with superficially located or high-flow AVMs and is related to turbulent blood flow within the arteriovenous shunt.
With the increasing availability and spatial resolution of modern MRI, cerebral AVMs are increasingly identified incidentally during imaging performed for unrelated symptoms such as headache or dizziness.
Catheter-based digital subtraction angiography remains the reference standard for detailed angioarchitectural assessment of a cerebral AVM and is an essential component of definitive treatment planning.
Management is individualized by an interdisciplinary neurovascular team. Treatment decisions take into account nidus size and location, Spetzler–Martin grade, previous hemorrhage, angioarchitectural risk factors, patient age and clinical condition, and the anticipated risks and benefits of each treatment modality.
Stereotactic radiosurgery is an established treatment option for appropriately selected cerebral AVMs, particularly when the nidus is located in a deep-seated or eloquent region where microsurgical resection would carry a substantial risk of neurological morbidity.
The radiosurgical effect develops progressively. Ionizing radiation induces endothelial injury and subsequent vascular remodeling, including intimal proliferation, progressive luminal narrowing, thrombosis, and fibrosis of the nidus vessels. Over time, this process may result in complete angiographic obliteration of the AVM.
During the latency period between radiosurgery and complete obliteration, a residual risk of hemorrhage remains. Definitive cure is established only after complete angiographic obliteration has been documented, generally by DSA.
Left: MRI demonstrating a frontal cerebral arteriovenous malformation.
Right: Digital subtraction angiography (DSA) provides precise visualization of the AVM angioarchitecture. The direct arteriovenous shunt, with no intervening capillary network between the arterial and venous circulations, is clearly demonstrated.
In this video, ERCM Director Prof. Muacevic explains the principles of stereotactic radiosurgery for the treatment of cerebral arteriovenous malformations.
The high level of treatment precision and the non-invasive nature of radiosurgery can offer important advantages in appropriately selected patients, particularly for AVMs in surgically challenging locations.
Complete AVM obliteration is confirmed by digital subtraction angiography (DSA), typically several years after stereotactic radiosurgery. Complete obliteration is defined angiographically by the absence of residual arteriovenous shunting through the nidus. MRI and MRA are valuable for longitudinal follow-up but do not replace catheter angiography when definitive confirmation of obliteration is required.
Yes. The therapeutic effect of radiosurgery is delayed, and complete obliteration generally develops gradually over a period of several years. Until complete obliteration has been achieved, a residual risk of hemorrhage remains. This latency interval is an important consideration when weighing radiosurgery against alternative treatment strategies.
An intracranial aneurysm is a focal pathological dilatation of an artery that may rupture and cause subarachnoid hemorrhage. A cerebral AVM, by contrast, is a complex arteriovenous shunt comprising a nidus, arterial feeders, and draining veins. Intracranial aneurysms are commonly treated by microsurgical clipping or endovascular techniques such as coiling or flow diversion, depending on aneurysm morphology and location. Radiosurgery is an established treatment modality for selected AVMs but is not a standard treatment for intracranial aneurysms. Flow-related or intranidal aneurysms may coexist with an AVM and require separate assessment.
Following AVM-related intracranial hemorrhage, acute management is directed first at stabilization and treatment of the hemorrhage and its neurological consequences. Once the patient is clinically stable, definitive management of the underlying AVM is considered because the risk of recurrent hemorrhage is increased after rupture. Stereotactic radiosurgery may remain an option in selected patients, often after the acute hematoma has resolved sufficiently to permit accurate target delineation. In patients with a large space-occupying hematoma, emergency hematoma evacuation with simultaneous or staged AVM treatment may be required.
Cerebral AVMs are vascular malformations that are generally believed to arise during vascular development and may remain clinically silent for many years. They often become symptomatic in young or middle adulthood. Most cerebral AVMs are sporadic; a minority occur in association with hereditary vascular disorders, particularly hereditary hemorrhagic telangiectasia (HHT; Osler–Weber–Rendu syndrome). Men and women are affected with approximately equal frequency.
We consider it essential that every patient fully understands the nature of the condition and the treatment options available in their individual case. For treatment enquiries, please use our contact form. You may also contact us by telephone during our opening hours or via our social media channels.
Each enquiry is reviewed individually and processed promptly.